Pulse Wave Velocity Assessment for Cardiovascular Risk Prognostication in ESKD: Weighting Recent Evidence

Author(s): Panagiotis I. Georgianos*, Vasilios Vaios, Theodoros Eleftheriadis, Pantelis E. Zebekakis, Vassilios Liakopoulos

Journal Name: Current Vascular Pharmacology

Volume 19 , Issue 1 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Among patients with end-stage kidney disease (ESKD), arterial stiffness is considered as a powerful predictor of cardiovascular (CV) morbidity and mortality. However, the relevance of aortic pulse wave velocity (PWV) as a prognostic biomarker for CV risk estimation is not yet fully clear.

Methods: We performed a systematic search of Medline/PubMed database from inception through August 21, 2019 to identify observational cohort studies conducted in ESKD patients and exploring the association of PWV with CV events and mortality.

Results: Whereas “historical” cohort studies showed aortic PWV to be associated with higher risk of CV and all-cause mortality, recent studies failed to reproduce the independent predictive value of aortic PWV in older ESKD patients. Studies using state-of-the-art prognostic tests showed that the addition of aortic PWV to standard clinical risk scores could only modestly improve CV risk reclassification. Studies associating improvement in PWV in response to blood pressure (BP)-lowering with improvement in survival cannot demonstrate direct cause-and-effect associations due to their observational design and absence of accurate methodology to assess the BP burden.

Conclusion: Despite the strong pathophysiological relevance of arterial stiffness as a mediator of CV disease in ESKD, the assessment of aortic PWV for CV risk stratification in this population appears to be of limited value. Whether aortic PWV assessment is valuable in guiding CV risk factor management and whether such a therapeutic approach is translated into improvement in clinical outcomes, is an issue of clinical relevance that warrants investigation in properly-designed randomized trials.

Keywords: Arterial stiffness, end-stage kidney disease, mortality, prognosis, pulse wave velocity, renal disease.

[1]
Georgianos PI, Pikilidou MI, Liakopoulos V, Balaskas EV, Zebekakis PE. Arterial stiffness in end-stage renal disease-pathogenesis, clinical epidemiology, and therapeutic potentials. Hypertens Res 2018; 41(5): 309-19.
[http://dx.doi.org/10.1038/s41440-018-0025-5] [PMID: 29531291]
[2]
Zanoli L, Lentini P, Briet M, et al. Arterial stiffness in the heart disease of CKD. J Am Soc Nephrol 2019; 30(6): 918-28.
[http://dx.doi.org/10.1681/ASN.2019020117] [PMID: 31040188]
[3]
Briet M, Boutouyrie P, Laurent S, London GM. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int 2012; 82(4): 388-400.
[http://dx.doi.org/10.1038/ki.2012.131] [PMID: 22534962]
[4]
London GM, Pannier B. Arterial functions: how to interpret the complex physiology. Nephrol Dial Transplant 2010; 25(12): 3815-23.
[http://dx.doi.org/10.1093/ndt/gfq614] [PMID: 20947536]
[5]
Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27(21): 2588-605.
[http://dx.doi.org/10.1093/eurheartj/ehl254] [PMID: 17000623]
[6]
Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55(13): 1318-27.
[http://dx.doi.org/10.1016/j.jacc.2009.10.061] [PMID: 20338492]
[7]
Ben-Shlomo Y, Spears M, Boustred C, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol 2014; 63(7): 636-46.
[http://dx.doi.org/10.1016/j.jacc.2013.09.063] [PMID: 24239664]
[8]
Kahn MR, Robbins MJ, Kim MC, Fuster V. Management of cardiovascular disease in patients with kidney disease. Nat Rev Cardiol 2013; 10(5): 261-73.
[http://dx.doi.org/10.1038/nrcardio.2013.15] [PMID: 23419899]
[9]
Ferreira JP, Girerd N, Pannier B, Rossignol P, London GM. High pulse-wave velocity defines a very high cardiovascular risk cohort of dialysis patients under age 60. Am J Nephrol 2017; 45(1): 72-81.
[http://dx.doi.org/10.1159/000453338] [PMID: 27898419]
[10]
Tripepi G, Agharazii M, Pannier B, et al. Pulse wave velocity and prognosis in end-stage kidney disease. Hypertension 2018; 71(6): 1126-32.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.10930] [PMID: 29712739]
[11]
Bao W, Wang F, Tang W. Aortic-brachial stiffness mismatch and mortality in peritoneal dialysis patients. Kidney Blood Press Res 2019; 44(1): 123-32.
[http://dx.doi.org/10.1159/000498876] [PMID: 30808839]
[12]
Fortier C, Mac-Way F, Desmeules S, et al. Aortic-brachial stiffness mismatch and mortality in dialysis population. Hypertension 2015; 65(2): 378-84.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.04587] [PMID: 25452473]
[13]
Matschkal J, Mayer CC, Sarafidis PA, et al. Comparison of 24-hour and office pulse wave velocity for prediction of mortality in hemodial-ysis patients. Am J Nephrol 2019; 49(4): 317-27.
[http://dx.doi.org/10.1159/000499532] [PMID: 30917369]
[14]
Sarafidis PA, Loutradis C, Karpetas A, et al. Ambulatory pulse wave velocity is a stronger predictor of cardiovascular events and all-cause mortality than office and ambulatory blood pressure in hemodialysis patients. Hypertension 2017; 70(1): 148-57.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.09023] [PMID: 28483919]
[15]
Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99(18): 2434-9.
[http://dx.doi.org/10.1161/01.CIR.99.18.2434] [PMID: 10318666]
[16]
Shoji T, Emoto M, Shinohara K, et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 2001; 12(10): 2117-24.
[PMID: 11562410]
[17]
Pannier B, Guérin AP, Marchais SJ, Safar ME, London GM. Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension 2005; 45(4): 592-6.
[http://dx.doi.org/10.1161/01.HYP.0000159190.71253.c3] [PMID: 15753232]
[18]
Tripepi G, Pannier B, D’Arrigo G, Mallamaci F, Zoccali C, London G. Reappraisal in two European cohorts of the prognostic power of left ventricular mass index in chronic kidney failure. Kidney Int 2017; 91(3): 704-10.
[http://dx.doi.org/10.1016/j.kint.2016.10.012] [PMID: 28010886]
[19]
London GM, Safar ME, Pannier B. Aortic aging in ESRD: Structural, hemodynamic, and mortality implications. J Am Soc Nephrol 2016; 27(6): 1837-46.
[http://dx.doi.org/10.1681/ASN.2015060617] [PMID: 26475595]
[20]
Papaioannou TG, Protogerou AD, Stamatelopoulos KS, Vavuranakis M, Stefanadis C. Non-invasive methods and techniques for central blood pressure estimation: procedures, validation, reproducibility and limitations. Curr Pharm Des 2009; 15(3): 245-53.
[http://dx.doi.org/10.2174/138161209787354203] [PMID: 19149616]
[21]
Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S, Kopple JD. Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension 2005; 45(4): 811-7.
[http://dx.doi.org/10.1161/01.HYP.0000154895.18269.67] [PMID: 15699452]
[22]
Zager PG, Nikolic J, Brown RH, et al. “U” curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 1998; 54(2): 561-9.
[http://dx.doi.org/10.1046/j.1523-1755.1998.00005.x] [PMID: 9690224]
[23]
Agarwal R. Blood pressure and mortality among hemodialysis patients. Hypertension 2010; 55(3): 762-8.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.144899] [PMID: 20083728]
[24]
Alborzi P, Patel N, Agarwal R. Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol 2007; 2(6): 1228-34.
[http://dx.doi.org/10.2215/CJN.02250507] [PMID: 17942773]
[25]
Georgianos PI, Agarwal R. blood pressure and mortality in long-term hemodialysis-time to move forward. Am J Hypertens 2017; 30(3): 211-22.
[PMID: 27661097]
[26]
Georgianos PI, Sarafidis PA, Malindretos P, Nikolaidis P, Lasaridis AN. Hemodialysis reduces augmentation index but not aortic or brachial pulse wave velocity in dialysis-requiring patients. Am J Nephrol 2011; 34(5): 407-14.
[http://dx.doi.org/10.1159/000331700] [PMID: 21934301]
[27]
Georgianos PI, Sarafidis PA, Haidich AB, et al. Diverse effects of interdialytic intervals on central wave augmentation in haemodialysis patients. Nephrol Dial Transplant 2013; 28(8): 2160-9.
[http://dx.doi.org/10.1093/ndt/gft085] [PMID: 23645477]
[28]
Karpetas A, Sarafidis PA, Georgianos PI, et al. Ambulatory recording of wave reflections and arterial stiffness during intra- and interdialytic periods in patients treated with dialysis. Clin J Am Soc Nephrol 2015; 10(4): 630-8.
[http://dx.doi.org/10.2215/CJN.08180814] [PMID: 25635033]
[29]
Koutroumbas G, Georgianos PI, Sarafidis PA, et al. Ambulatory aortic blood pressure, wave reflections and pulse wave velocity are elevated during the third in comparison to the second interdialytic day of the long interval in chronic haemodialysis patients. Nephrol Dial Transplant 2015; 30(12): 2046-53.
[http://dx.doi.org/10.1093/ndt/gfv090] [PMID: 25920919]
[30]
Salvi P, Scalise F, Rovina M, et al. Noninvasive estimation of aortic stiffness through different approaches. Hypertension 2019; 74(1): 117-29.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.12853] [PMID: 31132954]
[31]
Sarafidis PA, Georgianos PI, Karpetas A, et al. Evaluation of a novel brachial cuff-based oscillometric method for estimating central systolic pressure in hemodialysis patients. Am J Nephrol 2014; 40(3): 242-50.
[http://dx.doi.org/10.1159/000367791] [PMID: 25322847]
[32]
Vaios V, Georgianos PI, Pikilidou MI, et al. Accuracy of a newly-introduced oscillometric device for the estimation of arterial stiffness indices in patients on peritoneal dialysis: a preliminary validation study. Adv Perit Dial 2018; 34(2018): 24-31.
[PMID: 30480533]
[33]
Sugawara J, Hayashi K, Yokoi T, Tanaka H. Carotid-femoral pulse wave velocity: impact of different arterial path length measurements. Artery Res 2010; 4(1): 27-31.
[http://dx.doi.org/10.1016/j.artres.2009.11.001] [PMID: 20396400]
[34]
Sugawara J, Hayashi K, Yokoi T, Tanaka H. Age-associated elongation of the ascending aorta in adults. JACC Cardiovasc Imaging 2008; 1(6): 739-48.
[http://dx.doi.org/10.1016/j.jcmg.2008.06.010] [PMID: 19356510]
[35]
Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103(7): 987-92.
[http://dx.doi.org/10.1161/01.CIR.103.7.987] [PMID: 11181474]
[36]
Agarwal R, Lewis RR. Prediction of hypertension in chronic hemodialysis patients. Kidney Int 2001; 60(5): 1982-9.
[http://dx.doi.org/10.1046/j.1523-1755.2001.00997.x] [PMID: 11703618]
[37]
Agarwal R, Peixoto AJ, Santos SF, Zoccali C. Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 2006; 1(3): 389-98.
[http://dx.doi.org/10.2215/CJN.01891105] [PMID: 17699236]
[38]
Georgianos PI, Agarwal R. Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis. Nat Rev Nephrol 2016; 12(10): 636-47.
[http://dx.doi.org/10.1038/nrneph.2016.129] [PMID: 27573731]
[39]
Agarwal R, Satyan S, Alborzi P, et al. Home blood pressure measurements for managing hypertension in hemodialysis patients. Am J Nephrol 2009; 30(2): 126-34.
[http://dx.doi.org/10.1159/000206698] [PMID: 19246891]
[40]
Sarafidis PA, Loutradis C, Mayer CC, et al. Weak within-individual association of blood pressure and pulse wave velocity in hemodialysis is related to adverse outcomes. J Hypertens 2019; 37(11): 2200-8.
[http://dx.doi.org/10.1097/HJH.0000000000002153] [PMID: 31584899]
[41]
Ong KT, Delerme S, Pannier B, et al. Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihyper-tensive treatment: a meta-analysis of individual data in 294 patients. J Hypertens 2011; 29(6): 1034-42.
[http://dx.doi.org/10.1097/HJH.0b013e328346a583] [PMID: 21519280]
[42]
Shahin Y, Khan JA, Chetter I. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis 2012; 221(1): 18-33.
[http://dx.doi.org/10.1016/j.atherosclerosis.2011.12.005] [PMID: 22209214]
[43]
Safar ME. Can antihypertensive treatment reverse large-artery stiffening? Curr Hypertens Rep 2010; 12(1): 47-51.
[http://dx.doi.org/10.1007/s11906-009-0085-7] [PMID: 20425158]
[44]
Georgianos PI, Agarwal R. Effect of lisinopril and atenolol on aortic stiffness in patients on hemodialysis. Clin J Am Soc Nephrol 2015; 10(4): 639-45.
[http://dx.doi.org/10.2215/CJN.09981014] [PMID: 25784174]
[45]
Peters CD, Kjaergaard KD, Jensen JD, et al. No significant effect of angiotensin II receptor blockade on intermediate cardiovascular end points in hemodialysis patients. Kidney Int 2014; 86(3): 625-37.
[http://dx.doi.org/10.1038/ki.2014.69] [PMID: 24670413]
[46]
Verbeke F, Van Biesen W, Honkanen E, et al. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol 2011; 6(1): 153-9.
[http://dx.doi.org/10.2215/CJN.05120610] [PMID: 20829424]
[47]
Szeto CC, Kwan BC, Chow KM, Leung CB, Law MC, Li PK. Prognostic value of arterial pulse wave velocity in peritoneal dialysis patients. Am J Nephrol 2012; 35(2): 127-33.
[http://dx.doi.org/10.1159/000335580] [PMID: 22236995]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 1
Year: 2021
Published on: 03 April, 2020
Page: [4 - 11]
Pages: 8
DOI: 10.2174/1570161118666200403142451
Price: $65

Article Metrics

PDF: 29
HTML: 2